An investigation of the sleep architecture and consequent cognitive changes in olanzapine-treated depressed patients.
Phase of Trial: Phase III
Latest Information Update: 17 Dec 2015
At a glance
- Drugs Olanzapine (Primary)
- Indications Bipolar disorders; Major depressive disorder
- Focus Therapeutic Use
- 01 Sep 2010 Results presented at the 23rd Annual Congress of the European College of Neuropsychopharmacology in August 2010.
- 12 Jun 2009 Actual patient number (27) added as reported by ClinicalTrials.gov.
- 12 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History